As of Aug 18
| +0.0104 / +1.05%|
The 6 analysts offering 12-month price forecasts for Novavax Inc have a median target of 1.55, with a high estimate of 3.00 and a low estimate of 1.10. The median estimate represents a +55.00% increase from the last price of 1.00.
The current consensus among 7 polled investment analysts is to Hold stock in Novavax Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.